corpus.blog
41554 blogs · 4,450,554 posts Claim your blog
Record · corpus.blog/posts/01a0875e-1bb1-7222-9d70-4625d8635ca7

Nektar's Rezpegaldesleukin: Aiming To Restore Peripheral Immune Balance

chaotropy.com · published 14 June 2026

A record is what was published and who pointed at it. The text of the post is not held here: read it at the source, or at its Wayback capture.

Read the post at chaotropy.com Wayback capture
0blogs citing
First cited
—
Most recent
—
Rank this month
not ranked
Links from this post
36
Words captured
3,017

Cited by

No blog we hold has cited this post yet.

Links from this post

Link
Host
https://pmc.ncbi.nlm.nih.gov/articles/PMC9189744/
pmc.ncbi.nlm.nih.gov
https://pmc.ncbi.nlm.nih.gov/articles/PMC11076369/
pmc.ncbi.nlm.nih.gov
https://pmc.ncbi.nlm.nih.gov/articles/PMC8439107/
pmc.ncbi.nlm.nih.gov
https://link.springer.com/article/10.1007/s40265-020-01335-7
link.springer.com
https://pmc.ncbi.nlm.nih.gov/articles/PMC8648435/
pmc.ncbi.nlm.nih.gov
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1577115/full
frontiersin.org
https://www.fda.gov/drugs/drug-safety-and-availability/fda-requires-warnings-about-increased-risk-serious-heart-related-events-cancer-blood-clots-and-death
fda.gov
https://pmc.ncbi.nlm.nih.gov/articles/PMC10186346/
pmc.ncbi.nlm.nih.gov
https://www.frontiersin.org/journals/immunology/articles/10.3389/fimmu.2025.1641918/full
frontiersin.org
https://pmc.ncbi.nlm.nih.gov/articles/PMC9062472/
pmc.ncbi.nlm.nih.gov
https://www.nature.com/articles/s41392-022-01208-3
nature.com
https://www.nature.com/articles/s41435-023-00221-y
nature.com
https://www.nejm.org/doi/full/10.1056/NEJMoa1105143
nejm.org
https://www.nejm.org/doi/full/10.1056/NEJMoa1108188
nejm.org
https://www.nature.com/articles/s41467-024-53384-1
nature.com
https://www.sciencedirect.com/science/article/pii/S2589909022000132
sciencedirect.com
https://www.nature.com/articles/s41467-017-01886-6
nature.com
https://onlinelibrary.wiley.com/doi/full/10.1111/imm.13190
onlinelibrary.wiley.com
https://www.nejm.org/doi/full/10.1056/NEJMra020100
nejm.org
https://www.jacionline.org/article/S0091-6749(21
jacionline.org
https://www.nobelprize.org/prizes/medicine/2025/popular-information/
nobelprize.org
https://www.jci.org/articles/view/202216
jci.org
https://clinicaltrials.gov/study/NCT06136741
clinicaltrials.gov
https://ir.nektar.com/news-releases/news-release-details/rezolve-ad-phase-2b-study-rezpegaldesleukin-meets-primary-and
ir.nektar.com
https://ir.nektar.com/news-releases/news-release-details/nektar-presents-new-data-rezolve-ad-phase-2b-study
ir.nektar.com
https://ir.nektar.com/news-releases/news-release-details/new-rezolve-ad-maintenance-data-atopic-dermatitis-demonstrate
ir.nektar.com
https://clinicaltrials.gov/study/NCT06340360
clinicaltrials.gov
https://ir.nektar.com/news-releases/news-release-details/rezolve-aa-phase-2b-study-rezpegaldesleukin-establishes-proof
ir.nektar.com
https://www.sec.gov/Archives/edgar/data/906709/000119312525320009/d24251dex991.htm
sec.gov
https://www.sec.gov/Archives/edgar/data/906709/000119312525320009/d24251dex992.htm
sec.gov
Why Licensing A Dual-Mechanism Anti-IgE Antibody Could Be A Major Opportunity For Cue Biopharma Read at the source ↗
chaotropy.com
https://ir.nektar.com/news-releases/news-release-details/52-week-topline-results-16-week-blinded-treatment-extension
ir.nektar.com
https://www.statnews.com/wp-content/uploads/2023/08/nektar-vs-lilly-lawsuit.pdf
statnews.com
https://ir.nektar.com/news-releases/news-release-details/nektar-announces-promising-new-and-corrected-rezpegaldesleukin
ir.nektar.com
https://www.courtlistener.com/docket/67670334/nektar-therapeutics-v-eli-lilly-co/
courtlistener.com
https://www.sec.gov/Archives/edgar/data/0000906709/000121390026053369/ea028961101ex99-1.htm
sec.gov